Durolane 1082020
Durolane 1082020 is a synovial fluid supplementation medium (FDA Class III; FDA product code MOZ, Acid, Hyaluronic, Intraarticular) made by Saima Global Farma S.L., approved under FDA PMA P170007 on 29 Aug 2017 and listed in FDA GUDID since 13 Nov 2024 (UDI-DI 08437027710001), active as of 23 Oct 2026.
Active
PMA
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number08437027710001 | Date13 Nov 2024 | StatusListed |
| United States | FDA PMAAPPR | NumberP170007 | Date29 Aug 2017 | StatusActive |
Official records
- AccessGUDID record 08437027710001
- FDA PMA database P170007
From the FDA record
- Device description
- DUROLANE is a clear, viscous gel that contains highly purified sodium hyaluronate. This substance acts as a lubricant and shock absorber in the knee joint. DUROLANE is used to relieve knee pain due to osteoarthritis in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied sterile
Across registries
- FDA PMA P170007 decided 29 Aug 2017 Active
- FDA GUDID UDI-DI 08437027710001 listed 13 Nov 2024 Listed
Timeline
- Approved FDA PMA P170007
- Listed FDA GUDID 08437027710001
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Trade name
- Durolane
- Generic name
- Synovial fluid supplementation medium
- Model / reference
- 1082020
- Primary DI / UDI-DI
- 08437027710001
- PMA number
- FDA product code
- MOZ
- GMDN term
- Synovial fluid supplementation medium
- Device class
- Class III
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code MOZ (Acid, Hyaluronic, Intraarticular).
- Monovisc Injectable Intra-Articular Device by Anika Therapeutics, Inc.
- SYNOJOYNT by Mesoblast
- TriVisc by Channel-Markers Medical, LLC
- Synvisc Hylan G-F 20 by Sanofi Genzyme Corp.
- TRILURON by Fidia Farmaceutici S.p.A.
- Supartz by Seikagaku Corp.
- Gel-One by Seikagaku Corp.
- GenVisc 850 by Channel-Markers Medical, LLC
- Hymovis High Molecular Weight Viscoelastic Hyaluronan by Fidia Farmaceutici
- Orthovisc High Molecular Weight Hyaluronan by Anika Therapeutics, Inc.